Advantages and challenges of Newcastle disease virus as a vector for respiratory mucosal vaccines

Emergence of biased hypermutation in a heterologous additional transcription unit in recombinant lentogenic Newcastle disease virus

(2023) Hendrik de Buhr et al.   JOURNAL OF GENERAL VIROLOGY

Interim safety and immunogenicity results from an NDV-based COVID-19 vaccine phase I trial in Mexico

(2023) Samuel Ponce-de-León et al.   npj Vaccines

Development and Scalable Production of Newcastle Disease Virus-Vectored Vaccines for Human and Veterinary Use

(2022) Julia P. C. Fulber et al.   Viruses-Basel

Encoding of a transgene in-frame with a Newcastle disease virus protein increases transgene expression and stability

(2022) Mohamed A. Elbehairy et al.   JOURNAL OF GENERAL VIROLOGY

Intranasal administration of a live-attenuated recombinant newcastle disease virus expressing the SARS-CoV-2 Spike protein induces high neutralizing antibody levels and protects from experimental challenge infection in hamsters

(2022) Rik L. de Swart et al.   VACCINE

Intranasal immunization with avian paramyxovirus type 3 expressing SARS-CoV-2 spike protein protects hamsters against SARS-CoV-2

(2022) Hong-Su Park et al.   npj Vaccines

How nasal-spray vaccines could change the pandemic

(2022) Emily Waltz   NATURE

Newcastle Disease Virus-Like Particles Displaying Prefusion-Stabilized SARS-CoV-2 Spikes Elicit Potent Neutralizing Responses

(2021) Yongping Yang et al.   Vaccines

Recovery of Recombinant Avian Paramyxovirus Type-3 Strain Wisconsin by Reverse Genetics and Its Evaluation as a Vaccine Vector for Chickens

(2021) Mohamed A. Elbehairy et al.   Viruses-Basel

Identification of Novel T-Cell Epitopes on Infectious Bronchitis Virus N Protein and Development of a Multi-epitope Vaccine

(2021) Yifeng Qin et al.   JOURNAL OF VIROLOGY

Mucosal immunity to poliovirus

(2021) Ruth I. Connor et al.   Mucosal Immunology

Safety and Immunogenicity of a Newcastle Disease Virus Vector-Based SARS-CoV-2 Vaccine Candidate, AVX/COVID-12-HEXAPRO (Patria), in Pigs

(2021) Jesús Horacio Lara-Puente et al.   mBio

Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2

(2021) Jun-Gyu Park et al.   iScience

A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses

(2021) Weina Sun et al.   Nature Communications

Safety and Immunogenicity Analysis of a Newcastle Disease Virus (NDV-HXP-S) Expressing the Spike Protein of SARS-CoV-2 in Sprague Dawley Rats

(2021) Johnstone Tcheou et al.   Frontiers in Immunology

Intranasal vaccination with a Newcastle disease virus-vectored vaccine protects hamsters from SARS-CoV-2 infection and disease

(2021) Bryce M. Warner et al.   iScience

Characterization of thermostable Newcastle disease virus recombinants expressing the hemagglutinin of H5N1 avian influenza virus as bivalent vaccine candidates

(2020) Lulai Xu et al.   VACCINE

A Scalable Topical Vectored Vaccine Candidate against SARS-CoV-2

(2020) Mohammed A. Rohaim et al.   Vaccines

Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate

(2020) Weina Sun et al.   EBioMedicine

A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine

(2020) Weina Sun et al.   Vaccines

Innovation in Newcastle Disease Virus Vectored Avian Influenza Vaccines

(2019) Shin-Hee Kim et al.   Viruses-Basel

Engineering Newcastle disease virus as oncolytic vector for intratumoral delivery of immune checkpoint inhibitors and immunocytokines

(2019) Gayathri Vijayakumar et al.   JOURNAL OF VIROLOGY

A viral-vectored RSV vaccine induces long-lived humoral immunity in cotton rats

(2018) Jessica L. Grieves et al.   VACCINE

Generation of a recombinant Newcastle disease virus expressing two foreign genes for use as a multivalent vaccine and gene therapy vector

(2018) Haixia Hu et al.   VACCINE

Avian Paramyxovirus Type-3 as a Vaccine Vector: Identification of a Genome Location for High Level Expression of a Foreign Gene

(2017) Asuka Yoshida et al.   Frontiers in Microbiology

Paramyxovirus RNA synthesis, mRNA editing, and genome hexamer phase: A review

(2016) Daniel Kolakofsky   VIROLOGY

Development of a novel thermostable Newcastle disease virus vaccine vector for expression of a heterologous gene

(2015) Guoyuan Wen et al.   JOURNAL OF GENERAL VIROLOGY

STAT2 deficiency and susceptibility to viral illness in humans

(2013) S. Hambleton et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Avian paramyxovirus serotypes 2-9 (APMV-2-9) vary in the ability to induce protective immunity in chickens against challenge with virulent Newcastle disease virus (APMV-1)

(2012) Baibaswata Nayak et al.   VACCINE

Newcastle Disease Virus-Vectored Rabies Vaccine Is Safe, Highly Immunogenic, and Provides Long-Lasting Protection in Dogs and Cats

(2011) J. Ge et al.   JOURNAL OF VIROLOGY

Homologous Recombination in Negative Sense RNA Viruses

(2011) Guan-Zhu Han et al.   Viruses-Basel

Delivery to the lower respiratory tract is required for effective immunization with Newcastle disease virus-vectored vaccines intended for humans

(2009) Joshua M. DiNapoli et al.   VACCINE

Identification of a natural multi-recombinant of Newcastle disease virus

(2007) Guan-Zhu Han et al.   VIROLOGY